Inflatable container for transporting a biopharmaceutical fluid and system and method implementing such a container
US-2018354700-A1 · Dec 13, 2018 · US
US10136636B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10136636-B2 |
| Application number | US-201415029353-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2014 |
| Priority date | Oct 15, 2013 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Microfluidic cryopreservation technology is provided and particularly, but not exclusively, devices, systems, and methods for cryopreservation of biological materials such as oocytes, zygotes, and embryos. The present microfluidic devices and related systems and methods are configured to maintain biological material in a housing chamber when subjected to a constant volumetric flow of fluid of changing fluid density.
Opening claim text (preview).
We claim: 1. A microfluidic device for the cryopreservation of a biological material, comprising: a cryoprotectant solution input; a culture medium input; a serpentine mixing channel in fluid communication with the cryoprotectant solution input and the culture medium input; a housing chamber in fluid communication with the serpentine mixing channel; a port coupled to the housing chamber and configured to provide access for loading and unloading of biological material into the housing chamber; and a plurality of height-differential negative pressure holding channels each in fluid communication with the housing chamber, wherein the plurality of height-differential negative pressure holding channels is configured to maintain the biological material in the housing chamber when subjected to a constant volumetric flow of fluid of changing fluid density through the housing chamber. 2. The microfluidic device of claim 1 further comprising a vitrification solution. 3. The microfluidic device of claim 1 further comprising a cryoprotectant agent having a concentration that changes as a function of time. 4. The microfluidic device of claim 1 further comprising a biological material that is to be cryopreserved. 5. The microfluidic device of claim 1 wherein the biological material is an oocyte, a zygote, a stem cell, an embryo, an ovarian follicle, a embryoid body, an organoid, or a tissue. 6. The microfluidic device of claim 1 wherein the biological material is from a human. 7. The microfluidic device of claim 1 wherein the biological material is from a human having cancer or infertility. 8. The microfluidic device of claim 1 comprising polydimethylsiloxane. 9. The microfluidic device of claim 1 wherein the vitrification solution comprises an impermeable solute. 10. A system for the cryopreservation of a biological material, the system comprising: a) a device according to claim 1 ; b) a cyroprotectant solution comprising a cryoprotectant agent; c) a syringe pump in operable fluidic communication with the cyroprotectant solution input; d) a syringe pump in operable fluidic communication with the culture medium input; e) a thermodynamic heat pump to remove heat from the device and freeze biological material contained therein. 11. The system of claim 10 further comprising a microchip configured to perform instructions to control the syringe pump in operable fluidic communication with the cyroprotectant solution input and to control the syringe pump in operable fluidic communication with the culture medium input. 12. The system of claim 10 wherein a rate of delivery of the cyroprotectant solution is controllable and the rate of delivery of a culture medium is controllable. 13. The system of claim 10 wherein the cyroprotectant solution comprises an impermeable solute. 14. The system of claim 10 wherein the syringe pump in operable fluidic communication with the cyroprotectant solution input and the syringe pump in operable fluidic communication with the culture medium input provide a vitrification solution comprising a time-dependent concentration of the cryoprotectant agent. 15. The microfluidic system of claim 10 , wherein the plurality of height-differential negative pressure holding channels each have a negative height differential that generates suction in the housing chamber in an absence of syringe pump flow.
characterised by the means or forces applied to move the fluids · CPC title
Serpentine channels · CPC title
Human Necessities · mapped topic
characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.